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Abstract
Background: Totally implanted vascular access devices are frequently used in children for
repeated blood samples or intravenous treatments. This prospective study aims at identifying the
risk factors associated with infections, obstructions and surgical complications of these devices in
pediatric patients.
Methods: From January 2006 to January 2008, all children older than one year of age with a
diagnosis of solid or blood cell malignancy were included in the study. Insertion was performed by
the surgeon according to a standardized protocol after landmark-guided puncture of the subclavian
or internal jugular vein by a senior anesthesiologist. Dressing and post-operative care were
standardized. Every manipulation was prospectively recorded by specialized dedicated nurses, and
all patients were screened for complications one month post-surgery.
Results: 45 consecutive patients 1 to 16 years old were enrolled in the study. Mean age at the time
of procedure was 8.5 years (range 1.3–15.6; SD ± 4.88). There were 12 peroperative adverse
events in 45 procedures (27%), detailed as follows: 3 pneumothoraces (7%), 3 hematomas (7%), 6
arterial punctures (13%). Among these events, intervention was necessary for two pneumothorax
and one arterial puncture. There was no air embolism. At one month, we recorded 5 post-
operative complications (11%): 2 thrombotic obstructions, one unsightly scar, and one scapular
pain of unknown etiology. One patient needed repositioning of the catheter. There was no
catheter-related infection.
Conclusion: Prospective recording of TIVA insertion in children reveals a significant number of
early incidents and complications, mainly associated with the percutaneous puncture technique.
We found no infection in this series. Results of a longer follow-up in the same population are
pending.
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Totally implanted vascular access (TIVA) devices are fre-
quently used in children with long-term requirements for
blood samples or intravenous treatments [1,2]. In our
institution, TIVA use is an integral part of the manage-
ment of children and teenagers with solid and blood cell
malignancies. Despite many advantages over other kinds
of central venous access, use and insertion of TIVA are not
free from complications. Thrombosis and infections
account for the larger part, but surgical complications are
not absent [3-7].
In adult patients, the rate of TIVA-associated complica-
tions seems related to the duration of implantation, type
of perfusion (bolus vs. slow perfusion), and skin com-
mensal germs [8]. Mechanical and biophysical properties
and design of the materials have also been questioned [9].
No pediatric studies so far has addressed the relationship
between the complication rates and the number of
accesses to the TIVA device.
The aim of this prospective, mono-centric study is to iden-
tify the risk factors associated with infections, obstruc-
tions and surgical complications of TIVA in pediatric
patients. We report here our preliminary results regarding
surgical and early complications in 45 children.
Materials and methods
From January 2006 to January 2008, all patients older
than one year of age with a diagnosis of solid or blood cell
malignancy have been asked to participate in the study.
Patients younger than one year of age were excluded
because another type of TIVA device was used in these
patients. Patients with previous TIVA implantation or
patients with relapsing disease were excluded. The goals of
the study were explained to the parents by the operating
surgeon and informed consent was obtained.
Pre-operative workup included a Doppler ultrasound of
thoracic inlet vessels in case of previous central venous
line insertion. Platelet count under 60 × 109/L ; absolute
neutrophil count under 500/mm3; INR above 1.25 or an
activated partial thromboplastin time (aPTT) greater than
40s were all considered temporary contra-indications for
surgery.
TIVA insertion was performed according to a standardized
protocol designed for the purpose of the study, using only
one device (Celsite ST305 6.5F low profile, B-Braun, Mel-
sungen, Germany). The skin was prepped with a non-alco-
holic povidone-iodine solution. Insertion was performed
by the surgeon using a Seldinger technique after land-
mark-guided puncture of the subclavian or internal jugu-
lar vein by a senior anesthesiologist. The choice of the
venous approach was left to the anesthesiologist, depend-
ing on vascular permeability, patient's morphology and
personal preferences. Image intensification was used to
confirm proper placement of the catheter tip. Dressing
and post-operative care were also standardized. Standard
post-operative chest x-ray was routinely performed within
six hours from TIVA placement. Every TIVA manipulation
was then prospectively recorded by specialized nurses in a
booklet kept with the patient's file.
All patients were seen one month post-surgery by one of
the surgeons, and complications were recorded. Compli-
cation is defined according to Clavien's classification as a
deviation from the standard postoperative course requir-
ing intervention [10]. We also recorded adverse events
such as accidental arterial puncture that had no influence
on the procedure or on the post-operative course and that
were as such not considered complications. The number
of these adverse events, either perioperative or within the
first 30 days after the procedure, was the outcome of this
study.
Results
From January 2006 through January 2008, 45 consecutive
patients 1 to 16 years old were enrolled in the study. No
patient's legal representative denied informed consent.
Mean age at the time of procedure was 8.5 years (range
1.3–15.6; SD ± 4.88), Blood cell disorders accounted for
48%, solid tumor for 52% of patients. Mean operative
time was 51 min (range 30–220; SD ± 29.7). Mean
number of puncture attempts was 2 (range 1–6; SD ±
1.38). The right subclavian vein was chosen in 64% of
cases, right internal jugular vein in 25%, left subclavian
vein in 11%.
There were 12 peri operative adverse events in 45 proce-
dures (27%), detailed as follows: 3 pneumothoraces
(7%), 3 hematomas (7%), 6 arterial punctures (13%).
Among these events, intervention was necessary only in
the 3 cases of pneumothorax (in-patient observation in
one [Clavien grade 1] and drainage in 2 [grade 3]), and in
one case of arterial puncture (surgical exploration, grade
3). All pneumothoraces happened after a subclavian vein
approach and were appropriately detected by standard
post-operative chest x-ray. In one patient, the peel-off
introducer was inserted through the internal jugular vein
into the carotid artery, prompting surgical revision with-
out the need for suture and without sequela. Although
this does not strictly qualify as a complication (no devia-
tion from the ideal post-operative course), we did record
it as such because of the inherent risk linked to this mis-
hap. The other arterial punctures were detected immedi-
ately.Page 2 of 5
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tions (11%), detailed as follows: 2 thrombotic obstruc-
tions requiring thrombolysis with urokinase, one scar
considered unsightly and one scapular pain of unknown
etiology lasting for 4 weeks, which resolved with physio-
therapy.
In one patient, post-operative x-ray showed misplacement
of the central tip of the catheter, although its position was
considered satisfactory on the fluoroscopic image in the
operation theater. The catheter was therefore repositioned
under anesthesia.
There were no catheter-related infection during the first 4
weeks after implantation.
The total number of complications was thus 9/45 proce-
dures (20%). Table 1 summarizes the complications, their
grade and the type of intervention required.
Discussion
Complications associated with totally implanted vascular
access devices are increasingly recognized [11,12]. Regret-
tably, most published series have a retrospective design,
which may underestimate complications. Our series
comes from a medium-sized university teaching hospital,
with a dedicated pediatric department. The three surgeons
involved in this study are all senior fellows or staff sur-
geons. Anesthesiologists involved are more numerous,
and are all senior fellows or staff pediatric anesthesiolo-
gists. We believe that this setting represents real-life condi-
tions for TIVA implantation in children.
Our results show that TIVA placement is not free from
incidents and complications, some of them potentially
dangerous. This study recorded every unintentional event
during and after port placement to point out all the diffi-
culties associated with this procedure. It is noteworthy
that many of these events do not qualify as complication
according to Clavien's classification. The 2 pneumothora-
ces requiring drainage, the catheter misplacement and the
arterial introducer misplacement are considered grade 3
complications, 4 other events qualify as grade 1 complica-
tions.
Accidental arterial puncture was the single most frequent
incident with 6/45 (13%) procedures. In one case, arterial
placement of the guidewire was not recognized and the
peel-off introducer was inserted in the carotid artery
before the mistake was diagnosed. The carotid artery was
surgically explored and the introducer removed under
direct vision. The carotid needed no suturing, the patient
suffered no sequelae, and the post-operative course was
not modified. However, because of the potential compli-
cation of an arterial wound, we did record this event as a
complication.
Pneumothorax was noted in 6.6% of the procedures, all of
them after a right subclavian approach, and accounted for
one third of all complications. All patients were asympto-
matic and pneumothorax was detected on routine post-
operative chest x-ray. As two of these conditions eventu-
ally required drainage, we believe that routine chest roent-
genogram within a few hours from surgery has its place in
the follow-up of patients with TIVA insertion.
There were no hemothorax, hemomediastinum, lesion of
the thoracic duct or nerve palsy.
The high incidence of puncture-related incidents and
complications have led us to reconsider our current prac-
tice of landmark-guided percutaneous central vein cannu-
lation in children over 12 months. Indeed, all surgical
complications in this series but one are related to punc-
ture and cannulation. Systematic surgical cut-down is an
option preferred by several institutions; another solution
is the use of ultrasound locating devices for identification
and puncture of the vein, which has been shown to facili-
tate successful central venous cannulation in pediatric
series [13-15]. The National Institute for Clinical Excel-
lence in the United Kingdom has issued recommenda-
tions supporting the use of ultrasound guidance for this
Table 1: Summary of complications
Patient's position in the series Operative complication Complication at one month Treatment Complication grade according to 
Clavien
3 pneumothorax drainage 3
7 pneumothorax drainage 3
9 scar wound care 1
14 obstruction thrombolysis 2
15 obstruction thrombolysis 2
20 introducer in the carotid 3
24 pneumothorax observation 1
26 pain physiotherapy 1
44 catheter misplacement re-operation 3Page 3 of 5
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better control of the venous access, and we are currently
evaluating the implementation of these guidelines at our
institution. Alternatives include port placement by the
interventional radiologist, which has been reportedly
highly successful in uncontrolled adult studies [17].
The need to reposition one catheter on post-operative day
one because of intracardiac placement underlines the dif-
ficulty to properly determine the location of the catheter-
tip under fluoroscopy. Several solutions have been pro-
posed but there is no universal agreement [18-20].
The 5 post-operative complications in 45 TIVA place-
ments (11%) is a figure similar to recently published data
in adults [12]. Apart from the catheter tip misplacement,
all were benign and required supportive care only. There
were no infection, no leakage, no chamber displacement
and no costo-clavicular pinch-off phenomenon.
This series of patients are currently being followed-up pro-
spectively to assess the relationship between complication
rate and the number of interventions on the device, which
has not been done in children yet. All of our patients have
now at least 6 months of follow-up and data are being
extracted for a later publication.
Conclusion
We conclude that prospective recording of TIVA insertion
in children reveals a significant number of incidents and
complications, mainly associated with the percutaneous
puncture technique. Four operative complications in 45
insertions (9%) required surgical intervention. We did not
investigate complications of surgical cut-down insertion.
There were 11% post-operative, benign complications
after TIVA implantation. We found no early infection in
our series. Results of a longer follow-up in the same pop-
ulation are pending.
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